Evaluation of choroidal thickness in patients with scleroderma

Eye
Erol CoşkunB Kısacık

Abstract

To investigate the choroidal thickness in patients with scleroderma and to compare them with healthy control subjects. Forty-six patients with scleroderma (3 male and 43 female) and 31 healthy controls (6 male and 25 female) were included in the study. Twenty-five patients had limited-type and 21 patients had diffuse-type scleroderma. Only left eyes of the patients and control subjects were used in the analysis. Demographic features of all the patients and control subjects were recorded. Each subject underwent ophthalmological examinations including refraction, visual acuity, intraocular pressure, axial length (AXL) measurement, slit-lamp biomicroscopy, and fundus examination. Body mass index (BMI) was estimated for all participants. There were no significant differences between the patients with scleroderma and the control subjects in terms of age, gender, BMI, mean AXL, and mean spherical equivalent refractive error (SE) (P=0.1, P=0.086, P=0.37, P=0.55, and P=0.072 respectively). The patients with scleroderma had significantly thinner nasal, temporal, and subfoveal choroid than the healthy control subjects (P1=0.012, P2=0.046, and P3<0.001, respectively). There were no significant differences between the patients with limited...Continue Reading

References

Apr 1, 1991·British Journal of Rheumatology·A KrausD Alarcon-Segovia
Jan 1, 1987·Ophthalmic Research·L SerupH Hagdrup
Nov 1, 1972·American Journal of Ophthalmology·T G FarkasD Archer
Apr 16, 2003·Archives of Ophthalmology·Norbert D Wangsa-Wirawan, Robert A Linsenmeier
Jul 26, 2005·Autoimmunity·Lazaros I Sakkas
Apr 11, 2007·Archives of Ophthalmology·Kaija PolakLeopold Schmetterer
Jan 29, 2008·Ophthalmic Research·S MilenkovicM Ivancevic-Milenkovic
Aug 19, 2008·Acta Ophthalmologica·Esmeralda DelgadoLuis Silva-Carvalho
Mar 21, 2009·Survey of Ophthalmology·Rajen TailorJeffrey Kwartz
May 10, 2011·Clinics·Beatriz de A F GomesHaroldo V Moraes
Nov 16, 2011·Current Rheumatology Reports·Bradley J Rabquer, Alisa E Koch
Mar 20, 2012·Investigative Ophthalmology & Visual Science·Shinichi UsuiTomohiro Iida
Jul 31, 2013·Ocular Immunology and Inflammation·Erol CoskunA Mesut Onat
Sep 30, 2014·Microvascular Research·Francesca IngegnoliUNKNOWN ACUTE study group
Dec 23, 2014·Acta Ophthalmologica·Preeti GuptaChing-Yu Cheng
Jan 7, 2015·Turkish Journal of Medical Sciences·Erol CoşkunIbrahim Erbağci
Mar 15, 2015·Retinal Cases & Brief Reports·Amro AbdellatiefJose S Pulido

❮ Previous
Next ❯

Citations

Nov 20, 2016·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Erdinc AydinServet Akar
Sep 3, 2021·Journal of Cosmetic Dermatology·Tayfun ŞahinSelim Cevher

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia Cerebrovascular Disease

Basal ganglia cerebrovascular disease is a condition where the blood vessels in the basal ganglia are damaged or malfunction. Discover the latest research on basal ganglia cerebrovascular disease here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Related Papers

Clinical Ophthalmology
Pichai JirarattanasopaPatama Bhurayanontachai
Seminars in Ophthalmology
Alime GunesVedat Ali Yurekli
Turkish Journal of Medical Sciences
Erol CoşkunIbrahim Erbagci
[Zhonghua yan ke za zhi] Chinese journal of ophthalmology
Jing ZengXiao-yan Ding
Cutaneous and Ocular Toxicology
Mehmet Serdar DervişoğullarıAslıhan Yüce
© 2022 Meta ULC. All rights reserved